Big Pharma

Experimental Pain Medication May Work Without Risk of Addiction

IT’S ABOUT TIME –

Feb. 2, 2024 – The drug, called VX-548, works by blocking pain signals from nerves in the body before they get to the brain. Unlike opioids, it works only on peripheral nerves, and not on the brain or spinal cord. That means it doesn’t carry the potential for addiction that opioids do.  “Eighty million patients receive a prescription for moderate to severe pain, and their choices are really limited,” Stuart Arbuckle, Executive Vice President and Chief Operating Officer at Vertex, said in an earnings call.

Painkillers like ibuprofen, muscle relaxers, and antidepressants typically carry few side effects but are often not potent enough to relieve moderate to severe pain. Opioids, on the other hand, can be powerful therapies but come with serious side effects.   

READ@VeryWellHealth

C Luke

Recent Posts

Archaeologists Uncover Previously Unknown Effect of Tobacco

ALWAYS WITH YOU – Nov. 2, 2024 - Archaeologists have uncovered a previously unknown effect…

3 days ago

In Tumultuous Times – Readers Turn to ‘Healing Fiction’

TURN OFF CNN – Nov. 7, 2024 - At Toshikazu Kawaguchi’s book signings, it’s not…

3 days ago

More Layoffs at Addiction Recovery Care Cuts Nearly Quarter of its Workforce

86ed AGAIN? – NOV. 4, 2024 - Two previous rounds of employee cuts in September…

3 days ago

Winners Foundation Marks 40-Years Helping Racetrack Workers Overcome Alcoholism & Addiction

BY A NOSE – Nov. 5, 2024 - Thoroughbred owner and recovering alcoholic Gino Roncelli…

3 days ago

Health Issues And Dr. Pepper Addiction

VIDEO – NO VALUE AT ALL – Nov. 4, 2024 - It all started innocently…

3 days ago

Medicaid Funding Hasn’t Curbed Overdose Deaths

WHAT WOULD? – Nov. 4, 2024 - Stephan Lindner, Ph.D., is lead author on a…

3 days ago